News
BEATW
0.0570
-5.00%
-0.0030
Weekly Report: what happened at BEAT last week (0601-0605)?
Weekly Report · 1d ago
HeartBeam (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
TipRanks · 06/02 18:30
HeartBeam Publishes JACC Study Showing Its Credit Card‑Sized ECG Device Can Predict Heart Attack Risk In Chest Pain Patients
Benzinga · 06/02 11:20
HeartBeam announces peer-reviewed article in JACC on HeartBeam ECG
TipRanks · 06/02 11:05
HeartBeam study in JACC Advances shows at-home ECG algorithm identifies heart attack risk in chest pain patients
PUBT · 06/02 11:01
HeartBeam posts investor deck on at-home, cable-free synthesized 12-lead ECG platform for arrhythmia assessment
PUBT · 06/01 23:51
Weekly Report: what happened at BEAT last week (0525-0529)?
Weekly Report · 06/01 10:12
HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
TipRanks · 05/26 17:00
Weekly Report: what happened at BEAT last week (0518-0522)?
Weekly Report · 05/25 10:15
Heartbeam Price Target Cut to $2.50/Share From $5.50 by HC Wainwright & Co.
Dow Jones · 05/22 11:11
Heartbeam Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 05/22 11:11
HC Wainwright & Co. Maintains Buy on HeartBeam, Lowers Price Target to $2.5
Benzinga · 05/22 11:01
HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright
TipRanks · 05/22 10:10
HEARTBEAM, INC. <BEAT.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $2.5 FROM $5.5
Reuters · 05/22 10:10
U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday
Reuters · 05/22 06:49
Weekly Report: what happened at BEAT last week (0511-0515)?
Weekly Report · 05/18 10:15
HeartBeam price target lowered to $5 from $8 at Benchmark
TipRanks · 05/15 14:03
Heartbeam Price Target Cut to $5.00/Share From $8.00 by Benchmark
Dow Jones · 05/15 12:47
Heartbeam Is Maintained at Speculative Buy by Benchmark
Dow Jones · 05/15 12:47
Benchmark Maintains Speculative Buy on HeartBeam, Lowers Price Target to $5
Benzinga · 05/15 12:37
More
Webull provides a variety of real-time BEATW stock news. You can receive the latest news about Heartbeam through multiple platforms. This information may help you make smarter investment decisions.
About BEATW
HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.